View CartView Cart
Shopping Cart" title="Shopping Cart
Categories
ACE Customers Say

Faster than I expected. Got me out of a jam and we appreciate it. ... read more

-John Sever, PA

View All | Submit Your Own
Newsletter Signup" title="Newsletter Signup
Sign up today and be the first to hear about all our news updates and offers.
We respect your privacy.
Find us on Facebook E-commerce by Yahoo! This shopping cart employs the highest industry strength security: 256 bit SSL We accept Master Card, Visa, American Express, and Discover
Home > Office Supplies > Binders & Binding Supplies > Pocket Folders > Oxford > OxfordŽ Twin-Pocket Portfolio, Embossed Leather Grain Paper, Pink ESS57568

OxfordŽ Twin-Pocket Portfolio, Embossed Leather Grain Paper, Pink ESS57568

OxfordŽ
Oxford
OxfordŽ Twin-Pocket Portfolio, Embossed Leather Grain Paper, Pink ESS57568
Leatherette-grained stock provides a richer look and feel. Die-cut business card slot on inside front pocket keeps contact information at hand.
https://www.aceofficemachines.comoxford-twin-pocket-portfolio-embossed-leather-grain-paper-pink-ess57568.html
12.04USDIn stock
OxfordŽ Twin-Pocket Portfolio, Embossed Leather Grain Paper, Pink ESS57568click image to enlarge
OxfordŽ Twin-Pocket Portfolio, Embossed Leather Grain Paper, Pink ESS57568OxfordŽ Twin-Pocket Portfolio, Embossed Leather Grain Paper, Pink ESS57568
Item #ESS57568
ManufacturerESSELTE PENDAFLEX CORP.
BrandOxfordŽ
AvailabilityUsually ships the next business day
Regular Price$21.48
Sale Price$12.04( You Save 44% )
Please call for availability!


Description
Specifications
Product Reviews
Leatherette-grained stock provides a richer look and feel. Die-cut business card slot on inside front pocket keeps contact information at hand.
  • Leatherette-grained stock provides a richer look and feel.
  • Business card slot keeps contact information at hand.
  • Esselte Corporation will donate $.35 for each box of folders sold to The Breast Cancer Research FoundationŽ which is dedicated to preventing breast cancer and finding a cure in our lifetime by funding clinical and genetic research worldwide.